Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Incidence of opportunistic illness before and after initiation of highly active antiretroviral therapy in children.

Nesheim SR, Hardnett F, Wheeling JT, Siberry GK, Paul ME, Emmanuel P, Bohannon B, Dominguez K; LEGACY Consortium.

Pediatr Infect Dis J. 2013 Oct;32(10):1089-95. doi: 10.1097/INF.0b013e31829ee893.

2.

Use of nucleoside reverse transcriptase inhibitor-only regimens in HIV-infected children and adolescents.

Neely M, Rutstein R, Del Bianco G, Heresi G, Barton T, Wiznia A, Wiegand R, Wheeling T, Bohannon B, Dominguez K; LEGACY Consortium.

Pediatr Infect Dis J. 2013 Sep;32(9):e370-6. doi: 10.1097/INF.0b013e31828e8c09.

3.

Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.

Setse R, Siberry GK, Moss WJ, Gravitt P, Wheeling T, Bohannon B, Dominguez K; Legacy Consortium.

J Pediatr Adolesc Gynecol. 2012 Feb;25(1):27-34. doi: 10.1016/j.jpag.2011.09.002. Epub 2011 Nov 16.

4.

Associations of medically documented psychiatric diagnoses and risky health behaviors in highly active antiretroviral therapy-experienced perinatally HIV-infected youth.

Kapetanovic S, Wiegand RE, Dominguez K, Blumberg D, Bohannon B, Wheeling J, Rutstein R; LEGACY Consortium.

AIDS Patient Care STDS. 2011 Aug;25(8):493-501. doi: 10.1089/apc.2011.0107. Epub 2011 Jul 11.

Supplemental Content

Loading ...
Support Center